Mark Ledwidge: Clinical Trials

1 trial sponsored by Mark Ledwidge, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Mark Ledwidge: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
Sacubitril-Valsartan, Valsartan - Atrial Remodeling, Myocardial Dysfunction
Phase 2UnknownMark Ledwidge2502015-12-162021-05-11

Conditions studied

Atrial Remodeling (1)  ·  Hypertension (1)  ·  Myocarditis (1)  ·  Myositis (1)  ·  Ventricular Dysfunction (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Remodeling (1)

Interventions

Valsartan (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Countries

Ireland (1)

Top investigators

Fiona Ryan, Co-Investigator, PhD (1)

Results publications

PMID 36884247, PMID 42349572

NIH funding

2015 (1)